1
|
Kassab AE. N-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years. Curr Pharm Des 2024; 30:333-351. [PMID: 38303528 DOI: 10.2174/0113816128282470240117072322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 12/30/2023] [Accepted: 01/05/2024] [Indexed: 02/03/2024]
Abstract
Due to its important biological and pharmacological properties, in the field of medicinal chemistry and drug discovery, the N-acylhydrazone motif has shown to be extremely adaptable and promising. This scaffold has become a crucial component in the synthesis of numerous bioactive agents. N-Acylhydrazones are also interesting biological and synthetic tools due to their easy and straightforward synthesis. The current review provides a summary of the analgesic and anti-inflammatory activities of N-acylhydrazone derivatives over the past ten years. A brief discussion of structure-activity relationships is also provided which may guide researchers in medicinal chemistry to develop derivatives based on N-acylhydrazone scaffold as potent anti-inflammatory candidates.
Collapse
Affiliation(s)
- Asmaa E Kassab
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt
| |
Collapse
|
2
|
Li M, Li M, Hou Y, HE H, Jiang R, Wang C, Sun S. Ferroptosis triggers airway inflammation in asthma. Ther Adv Respir Dis 2023; 17:17534666231208628. [PMID: 37947059 PMCID: PMC10638875 DOI: 10.1177/17534666231208628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2023] [Accepted: 09/29/2023] [Indexed: 11/12/2023] Open
Abstract
Ferroptosis is a regulatory cell death characterized by intracellular iron accumulation and lipid peroxidation that leads to oxidative stress. Many signaling pathways such as iron metabolism, lipid metabolism, and amino acid metabolism precisely regulate the process of ferroptosis. Ferroptosis is involved in a variety of lung diseases, such as acute lung injury, chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Increasing studies suggest that ferroptosis is involved in the development of asthma. Ferroptosis plays an important role in asthma. Iron metabolism disorders, lipid peroxidation, amino acid metabolism disorders lead to the occurrence of ferroptosis in airway epithelial cells, and then aggravate clinical symptoms in asthmatic patients. Moreover, several regulators of ferroptosis are involved in the pathogenesis of asthma, such as Nrf2, heme oxygenase-1, mevalonate pathway, and ferroptosis inhibitor protein 1. Importantly, ferroptosis inhibitors improve asthma. Thus, the pathogenesis of ferroptosis and its contribution to the pathogenesis of asthma help us better understand the occurrence and development of asthma, and provide new directions in asthma treatment. This article aimed to review the role and mechanism of ferroptosis in asthma, describing the relationship between ferroptosis and asthma based on signaling pathways and related regulatory factors. At the same time, we summarized current observations of ferroptosis in eosinophils, airway epithelial cells, and airway smooth muscle cells in asthmatic patients.
Collapse
Affiliation(s)
- Minming Li
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
- Pediatric Medicine Class One, Kunming Medical University, Kunming, China
| | - Min Li
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
| | - Yunjiao Hou
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
| | - Huilin HE
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
| | - Ruonan Jiang
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
- Pediatric Medicine Class One, Kunming Medical University, Kunming, China
| | - Chu Wang
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China
| | - Shibo Sun
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, No.295, Xichang Road, Wuhua District, Kunming 650032, China
| |
Collapse
|
3
|
Noé JP, de Souza-Ferro JN, da Silva-Rodrigues ÉE, da Silva-Júnior EF, Alexandre-Moreira MS, de Araújo-Junior JX, Barreto E. LQM10, a guanylhydrazone derivative, reduces nociceptive and inflammatory responses in mice. Fundam Clin Pharmacol 2022; 37:619-628. [PMID: 36579760 DOI: 10.1111/fcp.12862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 11/26/2022] [Accepted: 12/22/2022] [Indexed: 12/30/2022]
Abstract
In the present study, we examined the antinociceptive and anti-inflammatory activities of a guanylhydrazone derivative, (E)-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-guanylhydrazone hydrochloride (LQM10), in mice. The antinociceptive effect was determined by assessing behavioural responses in different pain models, while anti-inflammatory activity was examined in carrageenan-induced pleurisy. Intraperitoneal LQM10 administration reduced the acetic acid-induced nociceptive behaviour, a phenomenon that was unaltered by pretreatment with yohimbine, atropine, naloxone or glibenclamide. In the formalin assay, LQM10 reduced nociceptive behaviour only in the second phase, indicating an inhibitory effect on inflammatory pain. LQM10 did not alter the pain latency in the hot plate assay and did not impact the locomotor activity of mice in the rotarod assay. In the carrageenan-induced pleurisy assay, LQM10 treatment inhibited critical events involved in inflammatory responses, namely, leucocyte recruitment, plasma leakage and increased inflammatory mediators (tumour necrosis factor Like Properties of Chalchones and Flavonoid Derivatives [TNF]-α and interleukin [IL]-1β) in the pleural exudate. Overall, these results indicate that LQM10 exhibits antinociceptive effects associated with peripheral mechanisms and anti-inflammatory activity mediated via a reduction in leucocyte migration and proinflammatory mediators, rendering this compound a promising candidate for treating pain and inflammatory process.
Collapse
Affiliation(s)
- João Paulo Noé
- Laboratory of Cell Biology, Institute of Biological Sciences and Health, Federal University of Alagoas, Maceió, 57072-970, Brazil
| | - Jamylle Nunes de Souza-Ferro
- Laboratory of Cell Biology, Institute of Biological Sciences and Health, Federal University of Alagoas, Maceió, 57072-970, Brazil
| | - Érica Erlanny da Silva-Rodrigues
- Laboratory of Medicinal Chemistry, Pharmaceutical Sciences Institute, Federal University of Alagoas, Maceió, 57072-900, Brazil.,Research Group on Biological and Molecular Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, 57072-970, Brazil
| | - Edeildo Ferreira da Silva-Júnior
- Research Group on Biological and Molecular Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, 57072-970, Brazil
| | - Magna Suzana Alexandre-Moreira
- Laboratory of Pharmacology and Immunity, Institute of Biological Sciences and Health, Federal University of Alagoas, Maceió, 57072-970, Brazil
| | - João Xavier de Araújo-Junior
- Laboratory of Medicinal Chemistry, Pharmaceutical Sciences Institute, Federal University of Alagoas, Maceió, 57072-900, Brazil
| | - Emiliano Barreto
- Laboratory of Cell Biology, Institute of Biological Sciences and Health, Federal University of Alagoas, Maceió, 57072-970, Brazil
| |
Collapse
|
4
|
Chronic allergic asthma alters m6A epitranscriptomic tagging of mRNAs and lncRNAs in the lung. Biosci Rep 2022; 42:231936. [PMID: 36250525 DOI: 10.1042/bsr20221395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 10/14/2022] [Accepted: 10/14/2022] [Indexed: 12/14/2022] Open
Abstract
To evaluate the role of m6A methylation of mRNAs and long non-coding RNAs (lncRNAs) in chronic allergic asthma. Transcriptome-wide N6-methyladenosine (m6A) changes in BALB/c mice were profiled using immunoprecipitated methylated RNAs with microarrays in lung with chronic allergic asthma. Gene ontology (GO) and KEGG analyses were conducted. Target genes were verified by methylated RNA immunoprecipitation and real-time polymerase chain reaction (PCR). Specifically, the mRNA levels of m6A writers (METTL3, METTL14, and WTAP), and readers and erasers (FTO and ALKBH5) were estimated by real-time PCR analysis, using the SYBR-green method. IL17RB mRNA was also evaluated by PCR. Hematoxylin and eosin (H&E) staining showed that the airway and lung tissues in mice in the asthma group had extensive infiltration of inflammatory cells around the bronchioles, blood vessels, and alveoli. The lungs of those allergic asthma mice showed altered m6A epitranscriptome, whereby 1369 mRNAs and 176 lncRNAs were hypermethylated, and 197 mRNAs and 30 lncRNAs were hypomethylated (>1.5-fold vs control). Also, compared with the control group, IL17RB mRNA in lung of the asthmatic group was significantly hypermethylated (P<0.01). In the asthma group, the mRNA and the protein level of METTL14 (the key methyltransferase) and ALKBH5 (the major demethyltransferase) were significantly decreased compared with the control group (P<0.01). Chronic allergic asthma alters the lung m6A epitranscriptome, suggesting functional implications in the pathophysiology of refractory asthma. Data support methylated IL17RB mRNA possibly becoming a new therapeutic target for chronic allergic asthma.
Collapse
|
5
|
Acylhydrazones and Their Biological Activity: A Review. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27248719. [PMID: 36557851 PMCID: PMC9783609 DOI: 10.3390/molecules27248719] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 12/02/2022] [Accepted: 12/07/2022] [Indexed: 12/13/2022]
Abstract
Due to the structure of acylhydrazones both by the pharmacophore -CO-NH-N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.
Collapse
|
6
|
Pedrood K, Rezaei Z, Khavaninzadeh K, Larijani B, Iraji A, Hosseini S, Mojtabavi S, Dianatpour M, Rastegar H, Faramarzi MA, Hamedifar H, Hajimiri MH, Mahdavi M. Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors. BMC Chem 2022; 16:57. [PMID: 35909126 PMCID: PMC9341091 DOI: 10.1186/s13065-022-00848-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 07/08/2022] [Indexed: 03/19/2024] Open
Abstract
A novel series of diphenylquinoxaline-6-carbohydrazide hybrids 7a–o were rationally designed and synthesized as anti-diabetic agents. All synthesized compounds 7a–o were screened as possible α-glucosidase inhibitors and exhibited good inhibitory activity with IC50 values in the range of 110.6 ± 6.0 to 453.0 ± 4.7 µM in comparison with acarbose as the positive control (750.0 ± 10.5 µM). An exception in this trend came back to a compound 7k with IC50 value > 750 µM. Furthermore, the most potent derivative 7e bearing 3-fluorophenyl moiety was further explored by kinetic studies and showed the competitive type of inhibition. Additionally, the molecular docking of all derivatives was performed to get an insight into the binding mode of these derivatives within the active site of the enzyme. In silico assessments exhibited that 7e was well occupied in the binding pocket of the enzyme through favorable interactions with residues, correlating to the experimental results.
Collapse
|
7
|
Silva LP, Santos IP, Silva DKC, dos Reis BPZC, Meira CS, Castro MVBDS, dos Santos Filho JM, de Araujo-Neto JH, Ellena JA, da Silveira RG, Soares MBP. Molecular Hybridization Strategy on the Design, Synthesis, and Structural Characterization of Ferrocene- N-acyl Hydrazones as Immunomodulatory Agents. Molecules 2022; 27:molecules27238343. [PMID: 36500436 PMCID: PMC9737981 DOI: 10.3390/molecules27238343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Revised: 11/08/2022] [Accepted: 11/22/2022] [Indexed: 12/02/2022] Open
Abstract
Immunomodulatory agents are widely used for the treatment of immune-mediated diseases, but the range of side effects of the available drugs makes necessary the search for new immunomodulatory drugs. Here, we investigated the immunomodulatory activity of new ferrocenyl-N-acyl hydrazones derivatives (SintMed(141−156). The evaluated N-acyl hydrazones did not show cytotoxicity at the tested concentrations, presenting CC50 values greater than 50 µM. In addition, all ferrocenyl-N-acyl hydrazones modulated nitrite production in immortalized macrophages, showing inhibition values between 14.4% and 74.2%. By presenting a better activity profile, the ferrocenyl-N-acyl hydrazones SintMed149 and SintMed150 also had their cytotoxicity and anti-inflammatory effect evaluated in cultures of peritoneal macrophages. The molecules were not cytotoxic at any of the concentrations tested in peritoneal macrophages and were able to significantly reduce (p < 0.05) the production of nitrite, TNF-α, and IL-1β. Interestingly, both molecules significantly reduced the production of IL-2 and IFN-γ in cultured splenocytes activated with concanavalin A. Moreover, SintMed150 did not show signs of acute toxicity in animals treated with 50 or 100 mg/kg. Finally, we observed that ferrocenyl-N-acyl hydrazone SintMed150 at 100 mg/kg reduced the migration of neutrophils (44.6%) in an acute peritonitis model and increased animal survival by 20% in an LPS-induced endotoxic shock model. These findings suggest that such compounds have therapeutic potential to be used to treat diseases of inflammatory origin.
Collapse
Affiliation(s)
- Laís Peres Silva
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil
| | - Ivanilson Pimenta Santos
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil
| | | | | | - Cássio Santana Meira
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil
- Institute for Innovation in Advanced Health Systems (CIMATEC ISI SAS—University Center SENAI/CIMATEC), Salvador 41650-010, BA, Brazil
| | - Marcos Venícius Batista de Souza Castro
- Laboratory of Design and Synthesis Applied to Medicinal Chemistry-SintMed®, Center for Technology and Geosciences, Federal University of Pernambuco, Recife 50740-521, PE, Brazil
| | - José Maurício dos Santos Filho
- Laboratory of Design and Synthesis Applied to Medicinal Chemistry-SintMed®, Center for Technology and Geosciences, Federal University of Pernambuco, Recife 50740-521, PE, Brazil
| | - João Honorato de Araujo-Neto
- Multiuser Laboratory of Structural Crystallography, Institute of São Carlos, University of São Paulo, São Carlos 13566-590, SP, Brazil
| | - Javier Alcides Ellena
- Multiuser Laboratory of Structural Crystallography, Institute of São Carlos, University of São Paulo, São Carlos 13566-590, SP, Brazil
| | - Rafael Gomes da Silveira
- Multiuser Laboratory of Structural Crystallography, Institute of São Carlos, University of São Paulo, São Carlos 13566-590, SP, Brazil
- Department of Chemistry, Federal Institute of Goiás, Campus Ceres, Ceres 76300-000, GO, Brazil
| | - Milena Botelho Pereira Soares
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil
- Institute for Innovation in Advanced Health Systems (CIMATEC ISI SAS—University Center SENAI/CIMATEC), Salvador 41650-010, BA, Brazil
- Correspondence:
| |
Collapse
|
8
|
El-Gammal OA, El-Bindary AA, Sh. Mohamed F, Rezk GN, El-Bindary MA. Synthesis, characterization, design, molecular docking, anti COVID-19 activity, DFT calculations of novel Schiff base with some transition metal complexes. J Mol Liq 2022. [DOI: 10.1016/j.molliq.2021.117850] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
9
|
de Assis ACL, Moreira LMCDC, Rocha BP, Pereira MRB, de Melo DF, de Moura RO, de Azevedo EP, Oshiro-Junior JA, Damasceno BPGDL. N-acylhydrazone Derivative-Loaded Cellulose Acetate Films: Thermoanalytical, Spectroscopic, Mechanical and Morphological Characterization. Polymers (Basel) 2021; 13:polym13142345. [PMID: 34301102 PMCID: PMC8309645 DOI: 10.3390/polym13142345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 07/12/2021] [Accepted: 07/14/2021] [Indexed: 12/20/2022] Open
Abstract
Cellulose acetate (ACT) is one of the most important cellulose derivatives due to its biodegradability and low toxicity, presenting itself as one of the main substitutes for synthetic materials in the development of wound dressing films. The incorporation of a N-acylhydrazonic derivative (JR19), with its promising anti-inflammatory activity, may represent an alternative for the treatment of skin wounds. This work aims to develop and to physicochemically and mechanically characterize ACT films containing JR19. The films were prepared using the ‘casting’ method and further characterized by thermoanalytical and spectroscopic techniques. In addition, mechanical tests and morphological analysis were performed. Thermogravimetry (TG) and differential scanning calorimetry (DSC) analyses showed that the thermal events attributed to excipients and films were similar, indicating the absence of physical incompatibilities between ACT and JR19. Infrared spectroscopy showed that JR19 was incorporated into ACT films. The characteristic band attributed to C≡N (2279 to 2264 cm−1) was observed in the spectra of JR19, in that of the physical mixture of JR19/ACT, and, to a lesser extent, in the spectra of JR19 incorporated into the ACT film, suggesting some interaction between JR19 and ACT. X-ray diffraction (XRD) evidenced the suppression of the crystallinity of JR19 (diffraction peaks at 8.54°, 12.80°, 14.09°, 16.08°, 18.19°, 22.65°, 23.59°, 24.53°, 25.70°, 28.16° and 30.27°2θ) after incorporation into ACT films. The mechanical tests indicated the adequate integrity of the films and their resistance to bending. The morphological characterization showed JR19 crystals along with a homogeneously distributed porous structure throughout the surface of the films with an average diameter of 21.34 µm and 22.65 µm of the films alone and of those incorporating JR19F, respectively. This study was able to characterize the ACT films incorporating JR19, showing their potential to be further developed as wound healing dressings.
Collapse
Affiliation(s)
- Amaro César Lima de Assis
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Lívia Maria Coelho de Carvalho Moreira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Beatriz Patrício Rocha
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Milena Raissa Bezerra Pereira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Demis Ferreira de Melo
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Ricardo Olímpio de Moura
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Eduardo Pereira de Azevedo
- Graduate Program of Biotechnology, Laureate International Universities–Universidade Potiguar (UnP), Natal 59056-000, Rio Grande do Norte, Brazil;
| | - João Augusto Oshiro-Junior
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| | - Bolívar Ponciano Goulart de Lima Damasceno
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| |
Collapse
|
10
|
Schisandrin B Attenuates Airway Inflammation by Regulating the NF- κB/Nrf2 Signaling Pathway in Mouse Models of Asthma. J Immunol Res 2021; 2021:8029963. [PMID: 34258300 PMCID: PMC8261176 DOI: 10.1155/2021/8029963] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 06/10/2021] [Accepted: 06/16/2021] [Indexed: 12/21/2022] Open
Abstract
Background Asthma is a complex inflammatory disorder that plagues a large number of people. Schisandrin B is an active ingredient of the traditional Chinese herbal medicine Schisandra with various proven physiological activities such as anti-inflammatory and antioxidant activities. In this study, we explored the anti-inflammatory and antioxidant effects and provided the mechanistic insights into the activity of schisandrin B in a mouse model of ovalbumin- (OVA-) induced allergic asthma. Methods Male BALB/c mice were sensitized and challenged with OVA to induce asthma and treated with various doses (15 mg/kg, 30 mg/kg, and 60 mg/kg) of SCH to alleviate the features of allergic asthma, airway hyperresponsiveness, inflammatory response, OVA-specific immunoglobulin (Ig)E level, and pathological injury. Results Schisandrin B significantly attenuated the airway hyperresponsiveness induced by OVA. Moreover, schisandrin B administration suppressed inflammatory responses, reduced the level of IgE, and attenuated pathological injury. Mechanistically, schisandrin B treatment promoted the activation of nuclear erythroid 2-related factor 2 (Nrf2), but suppressed the stimulation of the NF-κB pathway caused by OVA. Conclusion Taken together, our study suggests that schisandrin B attenuates the features of asthmatic lungs by inhibiting the NF-κB pathway and activating the Nrf2 signaling pathway.
Collapse
|
11
|
Aarjane M, Slassi S, Amine A. Novel series of N-acylhydrazone based on acridone: Synthesis, conformational and theoretical studies. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2020.129079] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
12
|
Yang J, Liu XR, Yu MK, Yang WB, Yang ZW, Zhao SS. Co and Cu complexes with 2-acetylpyridine-4-hydroxy phenylacetyl acylhydrazone: Synthesis, crystal structures, CT-DNA/BSA binding behaviors, antibacterial activities and molecular docking studies. Polyhedron 2020. [DOI: 10.1016/j.poly.2020.114619] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
13
|
Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone. ARAB J CHEM 2020. [DOI: 10.1016/j.arabjc.2020.05.034] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
|
14
|
Jiang X, Tang G, Yang J, Ding J, Lin H, Xiang X. Synthesis of some new acylhydrazone compounds containing the 1,2,4-triazole structure and their neuritogenic activities in Neuro-2a cells. RSC Adv 2020; 10:18927-18935. [PMID: 35518339 PMCID: PMC9053900 DOI: 10.1039/d0ra02880k] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Accepted: 05/05/2020] [Indexed: 11/21/2022] Open
Abstract
In the present study, a novel series of acylhydrazone compounds (A0–A10) with the structure of 1,2,4-triazole have been designed and synthesized.
Collapse
Affiliation(s)
- Xia Jiang
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province
- College of Biological and Food Engineering
- Huaihua University
- Huaihua 418008
- P. R. China
| | - Genyun Tang
- School of Medicine
- Hunan Provincial Key Laboratory of Dong Medicine
- Hunan University of Medicine
- Huaihua
- P. R. China
| | - Jie Yang
- Hunan Engineering Laboratory for Preparation Technology of Polyvinyl Alcohol (PVA) Fiber Material
- College of Chemistry and Materials Engineering
- Huaihua University
- Huaihua 418008
- P. R. China
| | - Jiacheng Ding
- Hunan Engineering Laboratory for Preparation Technology of Polyvinyl Alcohol (PVA) Fiber Material
- College of Chemistry and Materials Engineering
- Huaihua University
- Huaihua 418008
- P. R. China
| | - Hongwei Lin
- Hunan Engineering Laboratory for Preparation Technology of Polyvinyl Alcohol (PVA) Fiber Material
- College of Chemistry and Materials Engineering
- Huaihua University
- Huaihua 418008
- P. R. China
| | - Xiaoliang Xiang
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province
- College of Biological and Food Engineering
- Huaihua University
- Huaihua 418008
- P. R. China
| |
Collapse
|